Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Principals and clinical applications of magnetic resonance cardiac spectroscopy in heart failure.

Literature DB >> 28386690

Principals and clinical applications of magnetic resonance cardiac spectroscopy in heart failure.

Abstract

Cardiac magnetic resonance spectroscopy (MRS) is a noninvasive method to assess by-products of myocardial metabolism. Recent developments in shorter scan protocols and more powerful field strengths have created interest in utilizing this technology in studying and characterizing the metabolic derangements in heart failure patients. Our lack of understanding in heart failure could be greatly enhanced by identifying the metabolic changes and eventually modifying metabolic substrate to achieve improved cardiac mechanics with the aid of this technology. However, there are several impediments for the widespread applicability of this technology. This review discusses the principals of human cardiac MRS and literature pertaining to use of MRS in patients with cardiomyopathy.

Entities: Disease Species

Keywords: Cardiomyopathy; Heart Failure; Magnetic resonance spectroscopy; Metabolic disease; Review

Mesh：

Year: 2017 PMID： 28386690 DOI： 10.1007/s10741-017-9611-x

Source DB: PubMed Journal: Heart Fail Rev ISSN： 1382-4147 Impact factor: 4.214

54 in total

1. 31P-MR spectroscopy in human end-stage heart failure during therapy with recombinant human growth hormone.

Authors: T Wittlinger; T Voigtländer; K F Kreitner; P Kalden; S Genth-Zotz; H Darius; M Thelen; J Meyer
Journal: MAGMA Date: 1998-09 Impact factor: 2.310

2. Metabolic response of normal human myocardium to high-dose atropine-dobutamine stress studied by 31P-MRS.

Authors: H J Lamb; H P Beyerbacht; R Ouwerkerk; J Doornbos; B M Pluim; E E van der Wall; A van der Laarse; A de Roos
Journal: Circulation Date: 1997-11-04 Impact factor: 29.690

3. Non-invasive determination of myocardial lipid content in Fabry disease by 1H-MR spectroscopy.

Authors: B Petritsch; H Köstler; W Machann; M Horn; A M Weng; J P Goltz; D Hahn; M Niemann; F Weidemann; C Wanner; M Beer
Journal: Rofo Date: 2012-08-14

4. Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function.

Authors: Sebastiaan Hammer; Marieke Snel; Hildo J Lamb; Ingrid M Jazet; Rutger W van der Meer; Hanno Pijl; Edo A Meinders; Johannes A Romijn; Albert de Roos; Johannes W A Smit
Journal: J Am Coll Cardiol Date: 2008-09-16 Impact factor: 24.094

5. Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus.

Authors: Rutger W van der Meer; Luuk J Rijzewijk; Hugo W A M de Jong; Hildo J Lamb; Mark Lubberink; Johannes A Romijn; Jeroen J Bax; Albert de Roos; Otto Kamp; Walter J Paulus; Robert J Heine; Adriaan A Lammertsma; Johannes W A Smit; Michaela Diamant
Journal: Circulation Date: 2009-04-06 Impact factor: 29.690

6. 31P-MR spectroscopic imaging in hypertensive heart disease.

Authors: J-P Heyne; R Rzanny; A Hansch; U Leder; J R Reichenbach; W A Kaiser
Journal: Eur Radiol Date: 2006-03-02 Impact factor: 5.315

7. Exacerbation of cardiac energetic impairment during exercise in hypertrophic cardiomyopathy: a potential mechanism for diastolic dysfunction.

Authors: Sairia Dass; Lowri E Cochlin; Joseph J Suttie; Cameron J Holloway; Oliver J Rider; Leah Carden; Damian J Tyler; Theodoros D Karamitsos; Kieran Clarke; Stefan Neubauer; Hugh Watkins
Journal: Eur Heart J Date: 2015-05-18 Impact factor: 29.983

8. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes.

Authors: Michaela Scheuermann-Freestone; Per L Madsen; David Manners; Andrew M Blamire; Robin E Buckingham; Peter Styles; George K Radda; Stefan Neubauer; Kieran Clarke
Journal: Circulation Date: 2003-06-16 Impact factor: 29.690

9. Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy.

Authors: Jenifer G Crilley; Ernest A Boehm; Edward Blair; Bheeshma Rajagopalan; Andrew M Blamire; Peter Styles; William J McKenna; Ingegerd Ostman-Smith; Kieran Clarke; Hugh Watkins
Journal: J Am Coll Cardiol Date: 2003-05-21 Impact factor: 24.094

10. Myocardial perfusion and oxygenation are impaired during stress in severe aortic stenosis and correlate with impaired energetics and subclinical left ventricular dysfunction.

Authors: Masliza Mahmod; Jane M Francis; Nikhil Pal; Andrew Lewis; Sairia Dass; Ravi De Silva; Mario Petrou; Rana Sayeed; Stephen Westaby; Matthew D Robson; Houman Ashrafian; Stefan Neubauer; Theodoros D Karamitsos
Journal: J Cardiovasc Magn Reson Date: 2014-04-29 Impact factor: 5.364

4 in total